Abstract
We review the clinical and imaging characteristics of the most common ovarian neoplasms in children and adolescents. Because of the widespread use of diagnostic imaging, incidental ovarian neoplasms might be encountered during the evaluation of abdominal pain, trauma or other indications and might pose a diagnostic dilemma. Conducting adequate imaging studies under these conditions is important, as management strategies differ according to the size and appearance of the lesion as well as the age of the patient. US dominates in gynecological imaging because of its excellent visualization, absence of ionizing radiation and sedation risks and comparatively low cost. For further examination of indeterminate lesions found using US, MRI is being used more progressively in this field, particularly for the evaluation of complex pelvic masses with the aim of distinguishing benign and malignant conditions and conditions requiring surgical intervention. CT is reserved primarily for tumor staging and follow-up and for emergency situations.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Although malignant ovarian neoplasms in girls are uncommon and account for less than 2% of all pediatric cancers [1–4], Pomeranz and Sabnis [5] reported that hospital admissions for ovarian masses overall represented approximately one-fifth as many emergency department admissions as did appendicitis during the same study period. In a retrospective 14-year review of 240 patients presenting at the Children’s Hospital of Philadelphia [6] with 251 ovarian masses, it was found that nearly half of the lesions (48.8%) were neoplastic in etiology. Brookfield and co-workers [3] reported an incidence for malignant ovarian tumors of 0.102 per 100,000 girls per year in girls age 9 years or younger, with a 10-fold increase in girls age 10–19 years, to 1,072 per 100,000 girls per year. The same study also demonstrated that it is extraordinarily uncommon for infants younger than 1 year to have a malignant ovarian neoplasm. However, a higher index of suspicion for malignancy is needed in girls age 1 to 8 years, particularly in those presenting with a chief complaint of an abdominal mass or precocious puberty [3, 7], as malignancy can be found in approximately a quarter of these cases. In the 9–19 years age group, benign entities such as cysts or benign neoplasms are more common than malignant lesions, and malignancy is found in only 10% of the cases [3, 7]. Although ovarian malignancies are uncommon in pediatric patients, they account for approximately 10–20% [2, 3, 8] of the cases presenting with an ovarian mass and result in a diagnostic dilemma.
Ovarian tumors are classified on the basis of their origin as germ cell, epithelial, sex cord stromal or miscellaneous tumors. The histological distribution of these tumors in younger patients significantly differs from that in the adult population, and unlike the case in adults, in whom malignant tumors of epithelial origin represent approximately 95% of all ovarian malignancies, the most common ovarian neoplasms in females younger than 20 are of germ cell origin [3, 6, 9, 10], which represent nearly 80% of cases [3]. A recent 15-year review of 424 girls presenting with ovarian masses found that germ cell tumors constituted 50% of all pediatric ovarian malignancies, sex cord stromal tumors 28%, epithelial tumors 17% and other lesions 4% (ovarian involvement by leukemia and lymphoma) [7].
Children with germ cell and sex cord stromal tumors might exhibit acute abdominal pain as a presenting symptom, which is related to torsion, rupture and hemoperitoneum [11]. However, Oltmann et al. [12] recently reported that most ovarian torsions are not related to an underlying neoplasm acting as a lead point, and that there is specifically a very low incidence of malignant ovarian tumors presenting with torsion. The likelihood of malignancy is actually greater for patients presenting with a chief complaint of an abdominal mass or precocious puberty [7].
Abnormal hormonal activity, such as isosexual precocious puberty, has been classically associated with estrogen secretion in juvenile granulosa cell tumors, whereas masculinization has been related to Sertoli-Leydig cell tumors as a result of androgen secretion [7, 13]. Increased serum levels of beta human chorionic gonadotrophin (β-HCG) and α-fetoprotein (α-FP) are virtually diagnostic for malignant ovarian germ cell tumors when positive, although diagnosis is inconclusive if negative [7, 14, 15], as they might be positive in only 50% of the cases [7]. Subsequent monitoring of β-HCG and α-FP can be used to monitor for early relapse. Increased preoperative levels of CA 125 are associated with poor prognosis [16] and are most commonly found in association with epithelial cell tumors [6]. Elevated serum LDH (lactic dehydrogenase) levels have been more specifically associated with dysgerminoma [17], while elevated α-FP levels are commonly seen in yolk sac and Sertoli-Leydig cell tumors. Imaging findings thought to be associated with a higher risk of malignancy include a solid or a heterogeneous appearance versus a cystic appearance, which is considered more reassuring for benign lesions, although cystic lesions harbor malignant cells in nearly 5% of cases [7]. Unlike in adults, in whom lesions greater than 4 cm are considered suspicious for harboring malignancy [18], in children, ovarian masses are worrisome for malignancy if they are larger than 7.5–8.0 cm [7, 14, 19]. In general, most malignant tumors are responsive to chemotherapy and have an excellent prognosis with optimal therapy [20–22].
Germ cell tumors
Ovarian germ cell tumors constitute the most common type of ovarian neoplasms in childhood and adolescence [11]. The most common presenting symptom for these tumors is abdominal pain, followed by abdominal distention and a palpable mass [20]. The histological subtypes of germ cell tumors according to the World Health Organization (WHO) include teratoma (mature, immature and mixed); dysgerminoma; endodermal sinus tumor, also called yolk sac tumors; embryonal carcinoma; polyembrioma; and ovarian nongestational choriocarcinoma [11]. Among malignant lesions, malignant teratomas are the most common histological subtype, constituting 38.5% of cases, followed by dysgerminoma, representing nearly 33%, and nondysgerminoma or mixed cell types, comprising approximately 28% of cases [22]. Among these, embryonal carcinomas, ovarian choriocarcinoma and polyembrioma are the least common types and usually present in a pure form in unusual cases [22]. Malignant germ cell tumors metastasize to the lungs, liver and peritoneum [23]. Children with gonadal dysgenesis are at increased risk for the development of germ cell tumors [24].
Mature cystic teratoma is the most common type of ovarian neoplasm in children [25] and the only benign form. At least two of the three germ cell layers, the ectoderm, mesoderm or endoderm, are present in these tumors [25]. Mature cystic teratomas are known for containing hair, muscle, teeth, bone and skin lining the wall and predominating at the Rokitansky nodule under pathological examination. Mature cystic teratomas are commonly called dermoid cysts because of the preponderance of ectodermal elements. Because of their various components, mature teratomas vary in appearance, particularly on US. The size of the dermoid plug and the magnitude and location of the calcified elements, as well as the composition of the fatty components, are considered the determining factors for this variable appearance [26]. Most frequently, they manifest as a unilocular cystic lesion, with a hyperechoic nodule protruding into the cyst lumen, the so-called Rokitansky nodule or dermoid plug (Fig. 1). This contains hair follicles and often fragments of bone or teeth. The “dermoid mesh” (Fig. 1) refers to multiple echogenic linear interfaces, representing hair fibers, that might be seen floating within the cyst [26–29]. A fat–fluid interface is a distinguishing feature of mature teratomas and it is related to the presence of echogenic sebum floating above hypoechoic serous fluid (Fig. 2) [25]. The “tip of the iceberg” sign (Fig. 3) refers to the US appearance of the dermoid plug as an echogenic mass in the near-field resulting in posterior shadowing that makes visualization of the bulk of the lesion difficult and hides the posterior wall of the cyst. Care should be taken not to confuse an echogenic loop of bowel for a diffusely echogenic mature teratoma and vice versa [25]. Conversely, on CT and MRI the appearance of mature teratomas is nearly pathognomonic and is characterized by the presence of intratumoral fat consisting of adipose tissue within the cyst wall or dermoid plug and of sebum within the cyst lumen [25]. The latter characteristic is the most specific imaging finding for the diagnosis of mature teratoma [30]. Fat presents a high signal intensity on T1-weighted sequences that is suppressed when utilizing fat-saturation sequences. Conversely, the high T1 signal of blood-related products or proteinaceous contents does not suppress on fat-saturation imaging. The presence of calcific components within the Rokitansky nodule facilitates the diagnosis of mature teratomas, particularly on CT scans because of their characteristic appearance in this modality [31–33].
The reported complications of ovarian teratomas include torsion, which is seen in nearly 15% of all cases; rupture; infection; malignant transformation and infrequently autoimmune hemolytic anemia and immune-mediated limbic encephalitis [28, 32, 34].
Immature teratomas typically affect a younger age group and have a worse prognosis [32]. These are classified according to their level of differentiation; because the most constant component is neural tissue, the level of malignancy is determined by the proportion and degree of neuroectodermal tissue differentiation. As stated previously, elevated pre-operative levels of β-HCG and α-FP are nearly diagnostic of malignant ovarian germ cell tumors; however, these might be present in only 50% of cases [7]. Subsequent monitoring of β-HCG and α-FP is generally utilized for relapse surveillance. With imaging, immature teratomas are usually larger and demonstrate prominent areas of soft tissue, scattered foci of fat and fewer calcifications (Figs. 4 and 5) [32]. According to Alotaibi and Navarro [35], the preponderance of a cystic component with variable amounts of fat and calcification favors the diagnosis of a mature teratoma, while a predominantly solid appearance with scattered foci of fat and calcification favors the diagnosis of immature types. Recently, Vaysse et al. [19] proposed a 7.5-cm cutoff size as an important criterion to differentiate preoperatively between benign and malignant neoplasms. Mature teratomas might be found in 10% of patients with contralateral immature neoplasms; Therefore bilateral involvement does not necessarily infer a malignant process [21].
Growing teratoma syndrome is an uncommon phenomenon that follows successful treatment of malignant nonseminomatous germ-cell tumors. Its incidence in children with immature teratomas has been reported to be as high as 30% [20]. It is characterized by the appearance of secondary masses that histologically consist of benign cells. Although the development of new or enlarging masses following treatment is considered recurrence of malignancy, this is not the case with a growing teratoma. These masses usually demonstrate better defined margins, increased density and foci of calcification. They characteristically initiate at the site of the original lesion and extend into remote locations. Recognition of this phenomenon is important to prevent confusion with tumor progression (Fig. 5) [28, 36, 37].
Dysgerminomas are the least differentiated type of germ cell tumors and are equivalent to seminomas in males. These tumors, whether pure or combined with other elements, are the most common form of malignant ovarian neoplasm mainly affecting adolescents and young girls. With imaging, they appear as a solid, lobulated mass because of their internal architecture, which exhibits thin fibrovascular septa that typically enhance following the administration of an intravenous contrast agent in MR imaging. It is not uncommon to observe calcifications or small cysts within these lesions, which might be the result of necrosis and hemorrhage [34, 38]. Bilateral involvement occurs in approximately 10–15% of these cases. Unlike other ovarian tumors, dysgerminomas are highly radiosensitive and pelvic and retroperitoneal lymph node spreading is more frequent than intraperitoneal seeding. The correlation of these tumors with elevated laboratory values of LDH helps support their diagnosis [4, 17, 21]. It is not uncommon for dysgerminomas to be found in combination with other germ cell tumors (Fig. 6). This is particularly true in cases of gonadal dysgenesis, in which they are commonly found in association with gonadoblastoma (Fig. 7) [21, 24].
Sex cord stromal neoplasms
Sex cord stromal neoplasms originate from nongerminative tissue and arise from sex-cord-derived cells (granulosa cells in the normal ovary, Sertoli cells in the testis and Sertoli cells in ovarian tumors) and ovarian stromal cells (fibroblasts, theca cells and Leydig cells) [39]. Although several histological types are found in this group, two main groups are commonly considered, the granulosa-theca cell tumors and the Sertoli-Leydig cell tumors. Sex cord stromal neoplasms are usually hormonally active and are classically associated either with isosexual precocious puberty (juvenile granulosa cell tumor), or virilization and hirsutism (Sertoli-Leydig cell tumors). However, Cecchetto and coworkers [40] recently reported that signs of abnormal hormonal secretion were found in only 9 out of 23 patients and that the most common presenting symptom was abdominal pain, with or without an associated abdominal mass. This is probably related to the increasing use of imaging, thus permitting early diagnosis and treatment.
Granulosa cell tumor types are the most common malignant sex cord stromal neoplasm. Granulosa cell tumors are unusual in the pediatric population, with the exception of juvenile granulosa cell tumors (JGCTs). JGCTs exhibit less aggressive behavior than that of the adult type and typically affect prepubescent girls. They are often associated with isosexual pseudoprecocity, presenting with breast and labial enlargement, pubic and axillary hair and vaginal discharge [41, 42]. These physical changes are related to the hyperestrogenic state induced by tumor secretion (estradiol secretion in hormonally active tumors). Postpubertal patients with hormonally active JGCTs might develop menstrual irregularities, menorrhagia, intermenstrual bleeding or amenorrhea [42]. JGCTs are usually unilateral in presentation and can reach large sizes. Most cases, approximately 90%, are diagnosed in early stages of disease and have a favorable prognosis [42–44]. Inhibin is the tumor marker used to monitor these lesions [42]. JGCTs have been associated with Ollier disease and Maffucci syndrome [39] and should be strongly considered in the differential diagnosis of young patients with these conditions presenting with an ovarian neoplasm. Under gross examination, the majority of JGCTs present with solid and cystic components. Both solid and cystic portions might contain associated hemorrhagic products [41]. Under microscopic examination, focal follicle formation is a typical feature, which might explain the multicystic appearance on imaging. Regarding imaging, granulosa cell tumors vary widely. Granulosa cell tumors present with a spectrum of imaging appearances related to their various histological appearances and different arrangements of tumor cells. They manifest as solid masses, as tumors with hemorrhagic or fibrotic changes (Fig. 8), as multilocular cystic lesions (Fig. 9) or as completely cystic neoplasms (Fig. 10) [45]. The heterogeneous appearance of their solid components is related to intratumoral bleeding, infarct, fibrous degeneration, and irregularly arranged tumor cells. Kim and Kim [46] categorized these neoplasms into two most common types: large multiseptated cystic masses, and medium solid masses with internal cystic components, which refers to single, well-defined solid lesions with internal cystic components. On MR imaging, specifically on T2-weighted sequences, these lesions exhibit a distinctive sponge-like appearance [39, 46, 47] associated with a solid lesion of intermediate signal and innumerable cystic spaces. Unusual presentations, including large unilocular cystic and entirely solid forms, have also been described [41, 46]. Intratumoral hemorrhagic products are a common finding in granulosa cell tumors and can be seen in as many as 70% of cases [46, 48]. Uterine changes such as uterine hyperplasia and endometrial thickening are not uncommon and are related to estrogenic effects [39, 45, 46].
Sertoli-Leydig cell tumors, formerly known as androblastomas or arrhenoblastomas, are classically associated with virilization. However, most of these neoplasms are nonfunctional and only 30–40% of all cases produce male hormones [40, 44, 45]. With US, these lesions appear as solid, predominantly hypoechoic lesions (Fig. 11), while on MRI they manifest as predominantly hypointense solid lesions on T2-weighted sequences, depending on their fibrous content. In some instances, these neoplasms are indistinguishable from granulosa cell tumors [34, 39].
Fibromas, thecomas or fibrothecomas and sclerosing stromal tumors are generally benign histotypes arising from the stromal elements of the ovaries. These tumors are infrequent and are even more unusual in the pediatric population [40]. Fibromas are rarely seen in patients younger than 40 years of age [39] and are classically associated with Meigs syndrome, ascites and right-side pleural effusion, which resolve following tumor resection. Thecomas and fibrothecomas are a spectrum of benign tumors with variable populations of both theca cells and fibroblasts [34, 39]. The theca cells account for the estrogenic effects of these neoplasms. Their US and MR imaging appearances are variable and depend on the amount of fibrous tissue, which typically demonstrates a low-signal on T1- and T2-weighted sequences [34, 39]. Additionally, tumors with a preponderance of fibrous tissue will demonstrate delayed, weak enhancement in dynamic contrast exams. With CT, fibrothecomas manifest as solid lesions with a variable degree of enhancement (Fig. 12). Calcifications may be present [49]. As these neoplasms increase in size, myxoid or cystic degeneration can occur, causing a heterogeneous appearance and less enhancement. A lack of enhancement of the neoplasm raises suspicion for ovarian torsion. Ascites has been reported in 30% to 82% of these patients [39, 49].
Other sex cord stromal tumors include sex cord tumor with annular tubules, sclerosing stromal tumors and gynandroblastoma. Sex cord tumor with annular tubules has morphological features of both granulosa cell and Sertoli cell tumors and might secrete estrogens, progesterone and a mullerian-inhibiting substance, which is used as a tumor marker of recurrence. Sex cord tumor with annular tubules is typically associated with Peutz-Jeghers syndrome, an autosomal-dominant condition caused by mutations in the SKT11 gene with loss of tumor suppressor activity. Individuals with this syndrome are at high risk for intestinal and extraintestinal malignancies, including pancreatic, breast and ovarian malignancies. When associated with Peutz-Jeghers syndrome, these tumors are usually small, tend to contain internal calcifications and can be bilateral. Conversely, patients with sex cord tumor with annular tubules in the absence of Peutz-Jeghers syndrome typically present with large, unilateral tumors (Fig. 13) [39, 50–52].
Epithelial neoplasms
Carcinomas account for approximately 95% of ovarian cancers in women of all ages, but they are extremely uncommon in pre-menarchal girls. Most epithelial neoplasms are serous, followed by other miscellaneous epithelial tumors, mucinous tumors, endometrioid tumors and clear cell tumors, in order of frequency. Each of these tumor types is further classified as benign, borderline or malignant, according to the clinical behavior of the tumor [53]. Serous and mucinous cystadenomas are the most common histological types in the pediatric age group, with serous types being more common than mucinous types [6]. These lesions initially manifest with torsion, particularly if their size ranges 8–10 cm. Surprisingly, torsion is not associated with lesions larger than 15 cm [54]. Serous cystadenomas present as unilocular or multilocular cystic masses with homogeneous cystic components and thin septations (Fig. 14) but without papillary excrescences. Mucinous cystadenomas are typically large, multiloculated cystic masses with thin septations and locules that contain fluids of differing MRI signal intensities. The locules in these tumors are typically small and numerous (Fig. 15) [4, 54–56]. Serous cystadenofibromas are relatively rare, benign, epithelial-lined cystic lesions characterized by the presence of a solid fibrous stroma within the lesion. With MR imaging, this solid component typically manifests with a very low signal on T2-weighted sequences (Fig. 16) [57, 58].
Miscellaneous lesions
Small cell carcinoma of the ovary is a rare and often lethal type of malignant tumor of the ovary primarily affecting young women between the ages of 9 and 43 years [59, 60]. In rare occasions these neoplasms are familial and possibly inherited [59, 60]. The cell lineage of this tumor type is unclear, and in the most recent WHO classification it was included in the group of miscellaneous tumors. These tumors are usually unilateral, with a propensity for intraabdominal spreading, and are frequently associated with paraendocrine hypercalcemia [61]. Their manifestations include fatigue, lethargy, polydypsia, and polyuria [62]. Other nonspecific clinical manifestations include abdominal pain and swelling, pelvic pain or mass [62]. Macroscopically, these neoplasms show predominantly solid tissue, with areas of hemorrhage or necrosis, and they are sometimes confounded with JGCT, even in their pathology [60]. These tumors are usually monitored through calcium levels. Therefore, in the concomitant presence of hypercalcemia and an ovarian mass in girls and adolescents, the diagnosis of small cell carcinoma of the ovary should be raised in the differential diagnosis (Fig. 17).
Metastatic spread to the ovary is rare in children, and unlike in adults, it usually occurs hematogenously. It is most commonly associated with mucinous adenocarcinoma of the colon, followed by Burkitt lymphoma, alveolar rhabdomyosarcoma, Wilms tumor, neuroblastoma, and retinoblastoma [63], in order of frequency. Bilateral involvement is encountered in as many as 56% of these patients [63]. Large or bilateral ovarian masses, which might be indistinguishable from the ovaries, should raise suspicion of an underlying malignancy elsewhere that has metastasized to the ovary. In these cases, the presence of metastatic foci on other organs provides a clue to the correct diagnosis. Burkitt-type non-Hodgkin lymphoma is an uncommon cause of ovarian masses; it has been described in pediatric patients, particularly in association with HIV/AIDS. Imaging in these cases might reveal solid lesions with small peripheral follicles (Fig. 18). Recognition of this entity is important, as management differs in such patients in whom chemotherapy is the initial treatment of choice [64, 65].
Conclusion
It is not particularly uncommon for children to present with or to be evaluated for ovarian masses, and most of these are benign and represent simple or complex cysts, ovarian torsion or benign neoplasms [5, 7, 13]. US is the imaging modality of choice for visualizing the reproductive system in the pediatric population, particularly for the initial work–up, whereas CT and MRI are useful for tumor staging and follow-up. Mature teratomas are the most common benign ovarian tumors in children and adolescents, and although their cross-sectional imaging appearance is pathognomonic, their US appearance is quite variable, which is related to the presence of varying amounts of fat, calcific and cystic components [25, 26, 31, 33, 35]. A malignant ovarian lesion should be suspected in patients with lesions larger than 7.5–8.0 cm, lesions with predominantly solid components and in 1- to 8-year-old patients, particularly in those presenting with an abdominal mass or precocious puberty [7, 14, 19].
References
Piver MS, Patton T (1986) Ovarian cancer in children. Semin Surg Oncol 2:163–169
Brown MF, Hebra A, McGeehin K et al (1993) Ovarian masses in children: a review of 91 cases of malignant and benign masses. J Pediatr Surg 28:930–932
Brookfield KF, Cheung MC, Koniaris LG et al (2009) A population-based analysis of 1,037 malignant ovarian tumors in the pediatric population. J Surg Res 156:45–49
von Allmen D (2005) Malignant lesions of the ovary in childhood. Semin Pediatr Surg 14:100–105
Pomeranz AJ, Sabnis S (2004) Misdiagnoses of ovarian masses in children and adolescents. Pediatr Emerg Care 20:172–174
Morowitz M, Huff D, von Allmen D (2003) Epithelial ovarian tumors in children: a retrospective analysis. J Pediatr Surg 38:331–335
Oltmann SC, Garcia N, Barber R et al (2010) Can we preoperatively risk stratify ovarian masses for malignancy? J Pediatr Surg 45:130–134
Oltmann SC, Garcia NM, Barber R et al (2010) Pediatric ovarian malignancies: how efficacious are current staging practices? J Pediatr Surg 45:1096–1102
Quirk JT, Natarajan N (2005) Ovarian cancer incidence in the United States, 1992–1999. Gynecol Oncol 97:519–523
Quirk JT, Natarajan N, Mettlin CJ (2005) Age-specific ovarian cancer incidence rate patterns in the United States. Gynecol Oncol 99:248–250
Koulouris CR, Penson RT (2009) Ovarian stromal and germ cell tumors. Semin Oncol 36:126–136
Oltmann SC, Fischer A, Barber R et al (2010) Pediatric ovarian malignancy presenting as ovarian torsion: incidence and relevance. J Pediatr Surg 45:135–139
Cass DL, Hawkins E, Brandt ML et al (2001) Surgery for ovarian masses in infants, children, and adolescents: 102 consecutive patients treated in a 15-year period. J Pediatr Surg 36:693–699
Hayes-Jordan A (2005) Surgical management of the incidentally identified ovarian mass. Semin Pediatr Surg 14:106–110
Patterson DM, Rustin GJ (2006) Controversies in the management of germ cell tumours of the ovary. Curr Opin Oncol 18:500–506
Salonen JT, Uimari P, Aalto JM et al (2007) Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium. Am J Hum Genet 81:338–345
Sheiko MC, Hart WR (1982) Ovarian germinoma (dysgerminoma) with elevated serum lactic dehydrogenase: case report and review of literature. Cancer 49:994–998
Stevens SK, Hricak H, Stern JL (1991) Ovarian lesions: detection and characterization with gadolinium-enhanced MR imaging at 1.5 T. Radiology 181:481–488
Vaysse C, Delsol M, Carfagna L et al (2010) Ovarian germ cell tumors in children. Management, survival and ovarian prognosis. A report of 75 cases. J Pediatr Surg 45:1484–1490
Panteli C, Curry J, Kiely E et al (2009) Ovarian germ cell tumours: a 17-year study in a single unit. Eur J Pediatr Surg 19:96–100
Pectasides D, Pectasides E, Kassanos D (2008) Germ cell tumors of the ovary. Cancer Treat Rev 34:427–441
Smith HO, Berwick M, Verschraegen CF et al (2006) Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol 107:1075–1085
Stranzinger E, Strouse PJ (2008) Ultrasound of the pediatric female pelvis. Semin Ultrasound CT MR 29:98–113
Cools M, Looijenga LH, Wolffenbuttel KP et al (2009) Disorders of sex development: update on the genetic background, terminology and risk for the development of germ cell tumors. World J Pediatr 5:93–102
Outwater EK, Siegelman ES, Hunt JL (2001) Ovarian teratomas: tumor types and imaging characteristics. Radiographics 21:475–490
Sheth S, Fishman E, Buck J et al (1988) The variable sonographic appearances of ovarian teratomas: correlation with CT. AJR 151:331–334
Beller MJ (1998) The “tip of the iceberg” sign. Radiology 209:395–396
Choudhary S, Fasih N, McInnes M et al (2009) Imaging of ovarian teratomas: appearances and complications. J Med Imaging Radiat Oncol 53:480–488
Servaes S, Victoria T, Lovrenski J et al (2010) Contemporary pediatric gynecologic imaging. Semin Ultrasound CT MR 31:116–140
Saba L, Guerriero S, Sulcis R et al (2009) Mature and immature ovarian teratomas: CT, US and MR imaging characteristics. Eur J Radiol 72:454–463
Surratt JT, Siegel MJ (1991) Imaging of pediatric ovarian masses. Radiographics 11:533–548
Park SB, Kim JK, Kim KR et al (2008) Imaging findings of complications and unusual manifestations of ovarian teratomas. Radiographics 28:969–983
Guinet C, Ghossain MA, Buy JN et al (1995) Mature cystic teratomas of the ovary: CT and MR findings. Eur J Radiol 20:137–143
Shanbhogue AK, Shanbhogue DK, Prasad SR et al (2010) Clinical syndromes associated with ovarian neoplasms: a comprehensive review. Radiographics 30:903–919
Alotaibi MO, Navarro OM (2010) Imaging of ovarian teratomas in children: a 9-year review. Can Assoc Radiol J 61:23–28
Nimkin K, Gupta P, McCauley R et al (2004) The growing teratoma syndrome. Pediatr Radiol 34:259–262
Postovsky S, Epelbaum M, Ben Itzhak O et al (2004) Growing teratoma syndrome treated by interferon alpha-2beta: case report and literature review. Pediatr Hematol Oncol 21:9–16
Tanaka YO, Kurosaki Y, Nishida M et al (1994) Ovarian dysgerminoma: MR and CT appearance. J Comput Assist Tomogr 18:443–448
Outwater EK, Wagner BJ, Mannion C et al (1998) Sex cord-stromal and steroid cell tumors of the ovary. Radiographics 18:1523–1546
Cecchetto G, Ferrari A, Bernini G et al (2011) Sex cord stromal tumors of the ovary in children: a clinicopathological report from the Italian TREP project. Pediatr Blood Cancer 56(7):1062–1067
Young RH, Dickersin GR, Scully RE (1984) Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases. Am J Surg Pathol 8:575–596
Pectasides D, Pectasides E, Psyrri A (2008) Granulosa cell tumor of the ovary. Cancer Treat Rev 34:1–12
Tanaka YO, Saida TS, Minami R et al (2007) MR findings of ovarian tumors with hormonal activity, with emphasis on tumors other than sex cord-stromal tumors. Eur J Radiol 62:317–327
Tanaka YO, Tsunoda H, Kitagawa Y et al (2004) Functioning ovarian tumors: direct and indirect findings at MR imaging. Radiographics 24(Suppl 1):S147–166
Jung SE, Rha SE, Lee JM et al (2005) CT and MRI findings of sex cord-stromal tumor of the ovary. AJR 185:207–215
Kim SH, Kim SH (2002) Granulosa cell tumor of the ovary: common findings and unusual appearances on CT and MR. J Comput Assist Tomogr 26:756–761
Morikawa K, Hatabu H, Togashi K et al (1997) Granulosa cell tumor of the ovary: MR findings. J Comput Assist Tomogr 21:1001–1004
Imaoka I, Wada A, Kaji Y et al (2006) Developing an MR imaging strategy for diagnosis of ovarian masses. Radiographics 26:1431–1448
Mak CW, Tzeng WS, Chen CY (2009) Computed tomography appearance of ovarian fibrothecomas with and without torsion. Acta Radiol 50:570–575
Swanger RS, Brudnicki A (2007) Ultrasound of ovarian sex-cord tumor with annular tubules. Pediatr Radiol 37:1270–1271
Shen K, Wu P-C, Lang J-H et al (1993) Ovarian sex cord tumor with annular tubules: a report of six cases. Gynecol Oncol 48:180–184
Bercaw JL, Sanchez J, Byrd RH et al (2010) Sex cord tumor with annular tubules in a young adolescent with Von Willebrand’s disease. J Pediatr Adolesc Gynecol 23:e111–e114
Iyer VR, Lee SI (2010) MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization. AJR 194:311–321
Massicot R, Rousseau V, Darwish AA et al (2009) Serous and seromucinous infantile ovarian cystadenomas—a study of 42 cases. Eur J Obstet Gynecol Reprod Biol 142:64–67
Jung SE, Lee JM, Rha SE et al (2002) CT and MR imaging of ovarian tumors with emphasis on differential diagnosis. Radiographics 22:1305–1325
Sri Paran T, Mortell A, Devaney D et al (2006) Mucinous cystadenoma of the ovary in perimenarchal girls. Pediatr Surg Int 22:224–227
Outwater EK, Siegelman ES, Talerman A et al (1997) Ovarian fibromas and cystadenofibromas: MRI features of the fibrous component. J Magn Reson Imaging 7:465–471
Cho SM, Byun JY, Rha SE et al (2004) CT and MRI findings of cystadenofibromas of the ovary. Eur Radiol 14:798–804
Young RH, Oliva E, Scully RE (1994) Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases. Am J Surg Pathol 18:1102–1116
Young RH, Oliva E, Scully RE (1995) Small cell carcinoma of the hypercalcemic type in the ovary. Gynecol Oncol 57:7–8
Scully RE (1993) Small cell carcinoma of hypercalcemic type. Int J Gynecol Pathol 12:148–152
Isonishi S, Nishii H, Saitou M et al (2008) Small cell carcinoma of the ovary: clinical and biological study. Int J Clin Oncol 13:161–165
McCarville MB, Hill DA, Miller BE et al (2001) Secondary ovarian neoplasms in children: imaging features with histopathologic correlation. Pediatr Radiol 31:358–364
Crawshaw J, Sohaib SA, Wotherspoon A et al (2007) Primary non-Hodgkin’s lymphoma of the ovaries: imaging findings. Br J Radiol 80:e155–158
Koukourgianni F, Harambat J, Ranchin B et al (2010) Malignancy incidence after renal transplantation in children: a 20-year single-centre experience. Nephrol Dial Transplant 25:611–616
Author information
Authors and Affiliations
Corresponding author
Additional information
CME activity
This article has been selected as the CME activity for the current month. Please visit the SPR website at www.pedrad.org on the Education page and follow the instructions to complete this CME activity.
Rights and permissions
About this article
Cite this article
Epelman, M., Chikwava, K.R., Chauvin, N. et al. Imaging of pediatric ovarian neoplasms. Pediatr Radiol 41, 1085–1099 (2011). https://doi.org/10.1007/s00247-011-2128-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-011-2128-x